AI Applications for Drug Discovery and Development is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Michael C. Song
Sr. Manager R&D, Device Development at MedImmune, USA

Profile

Michael Song is the head of Biologic Device Functionality, Safety and Digital Connectivity within AstraZeneca Biopharmaceutical Development. In his current role, he oversees device functionality and safety; primary container science and technology; biocompatibility; container closure integrity; and digital connectivity development. Prior to his current role, Michael was head of Device, Packaging, and Process Engineering department at Adello Biologics (part of Amneal Pharmaceuticals). He has held key technical positions at Stryker, Amgen, and Kavlico Corporation. Michael has led the development of both combination products as well as 510(k) medical devices. He received his postdoctoral training at Barrow Neurological Institute / St. Joseph Hospital and Medical Center (part of Dignity Health) and holds a BS in Electrical Engineering from Purdue University and PhD in Neuroscience and Toxicology from Iowa State University.

Michael C. Song's Network

Agenda Sessions

  • Minimising the loss of patient adherence in clinical trials

    , 12:00pm